Seegene, Inc. (KOSDAQ:096530)
31,550
+50 (0.16%)
Sep 11, 2026, 3:30 PM KST
Seegene Revenue
Seegene had revenue of 135.96B KRW in the quarter ending June 30, 2026, with 19.20% growth. This brings the company's revenue in the last twelve months to 509.27B, up 12.12% year-over-year. In the year 2025, Seegene had annual revenue of 474.23B with 14.48% growth.
Revenue (ttm)
509.27B
Revenue Growth
+12.12%
P/S Ratio
2.82
Revenue / Employee
669.22M
Employees
761
Market Cap
1.44T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 474.23B | 59.98B | 14.48% |
| Dec 31, 2024 | 414.25B | 46.88B | 12.76% |
| Dec 31, 2023 | 367.38B | -486.19B | -56.96% |
| Dec 31, 2022 | 853.56B | -517.27B | -37.73% |
| Dec 31, 2021 | 1.37T | 245.62B | 21.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 738.76B |
| CLASSYS | 369.11B |
| i-SENS | 326.19B |
| InBody Co.,Ltd | 263.89B |
| T&L Co., Ltd. | 175.16B |
| WON TECH | 167.35B |
| BioNote | 126.41B |
| L&C BIO Co.,LTD | 116.30B |